Compare VCEL & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | PGY |
|---|---|---|
| Founded | 1989 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1997 | N/A |
| Metric | VCEL | PGY |
|---|---|---|
| Price | $36.47 | $21.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $60.40 | $39.86 |
| AVG Volume (30 Days) | 592.9K | ★ 2.8M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 236.54 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | $258,716,999.00 | ★ $1,245,946,000.00 |
| Revenue This Year | $17.86 | $28.75 |
| Revenue Next Year | $18.55 | $17.23 |
| P/E Ratio | $148.09 | ★ N/A |
| Revenue Growth | 14.05 | ★ 28.33 |
| 52 Week Low | $29.24 | $8.27 |
| 52 Week High | $63.00 | $44.99 |
| Indicator | VCEL | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 36.24 |
| Support Level | $35.85 | $22.61 |
| Resistance Level | $42.68 | $25.19 |
| Average True Range (ATR) | 1.54 | 1.36 |
| MACD | -0.34 | 0.04 |
| Stochastic Oscillator | 9.01 | 2.35 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.